» Articles » PMID: 36651198

Lifestyle, Genetic Risk and Incidence of Cancer: a Prospective Cohort Study of 13 Cancer Types

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2023 Jan 18
PMID 36651198
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Genetic and lifestyle factors are associated with cancer risk. We investigated the benefits of adhering to lifestyle advice by the World Cancer Research Fund (WCRF) with the risk of 13 types of cancer and whether these associations differ according to genetic risk using data from the UK Biobank.

Methods: In 2006-2010, participants aged 37-73 years had their lifestyle assessed and were followed up for incident cancers until 2015-2019. Analyses were restricted to those of White European ancestry with no prior history of malignant cancer (n = 195 822). Polygenic risk scores (PRSs) were computed for 13 cancer types and these cancers combined ('overall cancer'), and a lifestyle index was calculated from WCRF recommendations. Associations with cancer incidence were estimated using Cox regression, adjusting for relevant confounders. Additive and multiplicative interactions between lifestyle index and PRSs were assessed.

Results: There were 15 240 incident cancers during the 1 926 987 person-years of follow-up (median follow-up = 10.2 years). After adjusting for confounders, the lifestyle index was associated with a lower risk of overall cancer [hazard ratio per standard deviation increase (95% CI) = 0.89 (0.87, 0.90)] and of eight specific cancer types. There was no evidence of interactions on the multiplicative scale. There was evidence of additive interactions in risks for colorectal, breast, pancreatic, lung and bladder cancers, such that the recommended lifestyle was associated with greater change in absolute risk for persons at higher genetic risk (P < 0.0003 for all).

Conclusions: The recommended lifestyle has beneficial associations with most cancers. In terms of absolute risk, the protective association is greater for higher genetic risk groups for some cancers. These findings have important implications for persons most genetically predisposed to those cancers and for targeted strategies for cancer prevention.

Citing Articles

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation.

Zhang J, Wang G, Liu J, Tang F, Wang S, Li Y Front Oncol. 2025; 15:1513622.

PMID: 40012546 PMC: 11860100. DOI: 10.3389/fonc.2025.1513622.


Cinobufagin: Unveiling the hidden bufadienolide's promise in combating alimentary canal cancer development and progression - a comprehensive review.

Leme Boaro B, de Lima E, Maria D, Rici R, Cressoni Araujo A, Landgraf Guiguer E Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39976716 DOI: 10.1007/s00210-025-03902-9.


Cancer prevalence and its determinants in Hungary: Analyzing data from the 2009, 2014, and 2019 European Health Interview Surveys.

Ghanem A, Faludi E, Bata R, Mezei E, Hadar V, More M PLoS One. 2025; 20(2):e0315689.

PMID: 39946492 PMC: 11825095. DOI: 10.1371/journal.pone.0315689.


EFHD1 Activates SIK3 to Limit Colorectal Cancer Initiation and Progression via the Hippo Pathway.

Huang Q, Tang X, Gan C, Deng Q, Zhi S, Huang Q J Cancer. 2025; 16(4):1348-1362.

PMID: 39895792 PMC: 11786025. DOI: 10.7150/jca.103229.


Utility of Polygenic Risk Scores (PRSs) in Predicting Pancreatic Cancer: A Systematic Review and Meta-Analysis of Common-Variant and Mixed Scores with Insights into Rare Variant Analysis.

Verras G, Hamady Z, Collins A, Tapper W Cancers (Basel). 2025; 17(2).

PMID: 39858023 PMC: 11764467. DOI: 10.3390/cancers17020241.


References
1.
Choi J, Jia G, Wen W, Shu X, Zheng W . Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK Biobank. Am J Clin Nutr. 2021; 113(4):810-820. PMC: 8023827. DOI: 10.1093/ajcn/nqaa404. View

2.
Arthur R, Wang T, Xue X, Kamensky V, Rohan T . Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank. J Natl Cancer Inst. 2020; 112(9):893-901. PMC: 7492765. DOI: 10.1093/jnci/djz241. View

3.
Olmedo-Requena R, Lozano-Lorca M, Salcedo-Bellido I, Jimenez-Pacheco A, Vazquez-Alonso F, Garcia-Caballos M . Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate Cancer. Nutrients. 2020; 12(3). PMC: 7146507. DOI: 10.3390/nu12030768. View

4.
Solans M, Chan D, Mitrou P, Norat T, Romaguera D . A systematic review and meta-analysis of the 2007 WCRF/AICR score in relation to cancer-related health outcomes. Ann Oncol. 2020; 31(3):352-368. DOI: 10.1016/j.annonc.2020.01.001. View

5.
Kachuri L, Graff R, Smith-Byrne K, Meyers T, Rashkin S, Ziv E . Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction. Nat Commun. 2020; 11(1):6084. PMC: 7695829. DOI: 10.1038/s41467-020-19600-4. View